DUSP5 and DUSP6 modulate corneal epithelial cell proliferation

被引:0
|
作者
Wang, Zheng [3 ]
Reinach, Peter S. [3 ]
Zhang, Fan [3 ]
Vellonen, Kati-Sisko [4 ]
Urtti, Arto [4 ]
Turner, Helen [1 ,2 ]
Wolosin, J. Mario [1 ,2 ]
机构
[1] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA
[3] SUNY State Coll Optometry, Dept Biol Sci, New York, NY USA
[4] Univ Helsinki, Ctr Drug Res, Helsinki, Finland
来源
MOLECULAR VISION | 2010年 / 16卷 / 183-84期
关键词
DUAL-SPECIFICITY PHOSPHATASES; ACTIVATED PROTEIN-KINASE; SIDE-POPULATION CELLS; MAP KINASE; STEM-CELLS; GENE-EXPRESSION; DIFFERENTIATION; INACTIVATION; CONJUNCTIVAL; PATHWAYS;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: Dual specificity phosphatases (DUSPs) modulate the duration and magnitude of phospho-activation of Erk1/2, p38 and JNK1/2, the terminal kinases (TKs) of the mitogen activated protein kinase (MAPK) cascades. Three DUSPs, DUSP1, DUSP5, and DUSP6, are overexpressed in ocular surface side population stem cells (SPSCs). Our objective was to identify the impact of these enzymes on TK phosphorylation and proliferation of corneal epithelial cells. Methods: SV40 immortalized (sv) and expanded fresh human corneal epithelial cells (efHCECs) were transduced with lentivectors to elicit expression of shRNAmir against DUSP1, DUSP5, and JNK1 to thereby create the DUSP1i, DUSP5i and JNKi cell sublines, or overexpress DUSP6 (henceforth DUSP6(+)), respectively. TK phosphorylation status and proliferation rates were determined by immunoblotting and H-3 thymidine uptake. Results: In both ef and svHCECs, EGF supplementation after a 24 h serum starvation caused a rapid 5-15 min spike in the phosphorylation of all three TK types. This was followed by gradual decreases to low phosphorylation levels within one h. These declines coincided with dramatic increases in DUSP1 and DUSP5 protein expression. In DUSP1i, the DUSP1 increase was abolished. All 3 TKs maintained high phosphorylation levels for at least 90 min and proliferation rates were unchanged from non-transduced cells. In DUSP5i, the DUSP5 protein increase was prevented, the post peak phosphorylation decrease occurred only on Erk1/2 and the proliferation rate increased by 50%-60%. In JNK1i, JNK1 was essentially knocked out and proliferation rates were also markedly elevated. At steady-state, DUSP1i maintained high levels of pJNK1/2 expression. In DUSP6(+) Erk1/2 phosphorylation was prevented and proliferation rates decreased to less than 50%. Conclusions: DUSP5 and DUSP6 selectively control ERK pathway activity and proliferation. The lack of an effect of DUSP1 knockdown on proliferation can be attributed to its pan-MAPK effect. The expected augmented proliferative response due to enhanced and prolonged phosphorylation of Erk1/2 following DUSP1 knockdown does not occur because a pJNK1/2 antiproliferative effect is simultaneously unleashed.
引用
收藏
页码:1696 / 1704
页数:9
相关论文
共 50 条
  • [21] Simvastatin suppresses renal cell carcinoma cells by regulating DDX5/DUSP5
    Qiu, Yu
    Zhao, Yakun
    Wang, Haipng
    Liu, Wei
    Jin, Chengluo
    Xu, Wanhai
    SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (04) : 337 - 343
  • [22] Regulation of an inhibitor of the MAP Kinase ERK; the Phosphatase DUSP6
    Bermudez, O.
    Jouandin, P.
    Rottier, J.
    Pages, G.
    Gimond, C.
    FEBS JOURNAL, 2009, 276 : 230 - 230
  • [23] DUSP5 expression associates with poor prognosis in human neuroblastoma
    Aurtenetxe, Olaia
    Zaldumbide, Laura
    Erramuzpe, Asier
    Lopez, Ricardo
    Lopez, Jose, I
    Cortes, Jesus M.
    Pulido, Rafael
    Nunes-Xavier, Caroline E.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2018, 105 (03) : 272 - 278
  • [24] A Missense Mutation in DUSP6 is Associated with Class III Malocclusion
    Nikopensius, T.
    Saag, M.
    Jagomaegi, T.
    Annilo, T.
    Kals, M.
    Kivistik, P. A.
    Milani, L.
    Metspalu, A.
    JOURNAL OF DENTAL RESEARCH, 2013, 92 (10) : 893 - 898
  • [25] DUSP6 phosphatase as a tumor suppressor in non-small cell lung cancer
    Perona, Rosario
    Moncho-Amor, Veronica
    Ibanez de Caceres, Inmaculada
    Pintado-Berninches, Laura
    Martin, Ester
    Quintanilla, Miguel
    Cortes-Sempere, Maria
    Sastre, Leandro
    Belda-Iniesta, Cristobal
    CANCER RESEARCH, 2015, 75
  • [26] Class III Malocclusion: Missense Mutations in DUSP6 Gene
    Nowrin, Shifat A.
    Basri, Rehana
    Alam, Mohammad Khursheed
    Jaafar, Saidi
    Mokhtar, Khairani Idah Binti
    PESQUISA BRASILEIRA EM ODONTOPEDIATRIA E CLINICA INTEGRADA, 2019, 19 (01):
  • [27] Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP6
    Boeckx, Carolien
    Deschoolmeester, Vanessa
    Wouters, An
    de Beeckx, Ken Op
    Pauwels, Patrick
    Vanderveken, Olivier
    van Camp, Guy
    Vanden Berghe, Wim
    Specenier, Pol
    Vermorken, Jan B.
    Peeters, Marc
    Baay, Marc
    Lardon, Filip
    CANCER RESEARCH, 2013, 73 (08)
  • [28] The cytotoxic action of BCI is not dependent on its stated DUSP1 or DUSP6 targets in neuroblastoma cells
    Thompson, Elliott M.
    Patel, Vruti
    Rajeeve, Vinothini
    Cutillas, Pedro R.
    Stoker, Andrew W.
    FEBS OPEN BIO, 2022, 12 (07): : 1388 - 1405
  • [29] DUSP6, a tumor suppressor, is involved in differentiation and apoptosis in esophageal squamous cell carcinoma
    Ma, Jianjuan
    Yu, Xiying
    Guo, Liping
    Lu, Shih Hsin
    ONCOLOGY LETTERS, 2013, 6 (06) : 1624 - 1630
  • [30] Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages
    Molina, Gabriela
    Vogt, Andreas
    Bakan, Ahmet
    Dai, Weixiang
    de Oliveira, Pierre Queiroz
    Znosko, Wade
    Smithgall, Thomas E.
    Bahar, Ivet
    Lazo, John S.
    Day, Billy W.
    Tsang, Michael
    NATURE CHEMICAL BIOLOGY, 2009, 5 (09) : 680 - 687